T cells expressing PSMA-CCR and suboptimal activation receptor (low-affinity PSCA-specific scFv) were effectively activated when co-cultured with PSCA+PSMA+ instead of PSCA+PSMA- cells, and showed enhanced protection against tumor cells in vitro and in vivo74. The gene discussed is FOLH1; the disease is neoplasm.